| Quarterly Financials | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 54 | 116 | 103 | 116 | 126 | 116 | 114 | 119 | 107 | 124 | 117 | 126 | 127 | 146 | 138 | 159 | 160 | 188 | 174 | 179 |
| Expenses | 38 | 62 | 54 | 58 | 66 | 62 | 63 | 68 | 65 | 72 | 69 | 72 | 73 | 82 | 82 | 92 | 95 | 107 | 102 | 105 |
| EBITDA | 16 | 54 | 49 | 59 | 60 | 54 | 51 | 51 | 43 | 52 | 48 | 54 | 54 | 64 | 55 | 66 | 65 | 81 | 72 | 73 |
| Operating Profit % | 27 % | 45 % | 46 % | 49 % | 46 % | 45 % | 43 % | 41 % | 38 % | 40 % | 39 % | 41 % | 40 % | 41 % | 38 % | 41 % | 39 % | 42 % | 40 % | 39 % |
| Depreciation | 12 | 14 | 13 | 13 | 12 | 13 | 13 | 15 | 14 | 16 | 20 | 11 | 13 | 14 | 15 | 16 | 17 | 17 | 18 | 19 |
| Interest | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 |
| Profit Before Tax | 1 | 36 | 33 | 43 | 44 | 38 | 34 | 31 | 24 | 31 | 22 | 37 | 36 | 45 | 35 | 44 | 42 | 57 | 47 | 47 |
| Tax | -1 | 9 | 8 | 11 | 11 | 10 | 8 | 8 | 6 | 8 | 6 | 9 | 9 | 11 | 9 | 10 | 10 | 15 | 11 | 13 |
| Net Profit | 2 | 27 | 25 | 32 | 33 | 28 | 26 | 24 | 18 | 24 | 17 | 28 | 26 | 34 | 26 | 34 | 32 | 42 | 35 | 35 |
| EPS in ₹ | 3.55 | 2.59 | 2.43 | 3.08 | 3.23 | 2.72 | 2.48 | 2.33 | 1.71 | 2.29 | 1.60 | 2.69 | 2.57 | 3.26 | 2.53 | 3.27 | 3.06 | 4.09 | 3.42 | 3.38 |
Vijaya Diagnostic Centre
948.60
-6.60
(-0.69%)
Market Cap
9,736.08 Cr
EPS
11.62
PE Ratio
68.18
Dividend Yield
0.21 %
Industry
Healthcare Services52 Week High
1,275.00
52 Week Low
730.00
PB Ratio
12.32
Debt to Equity
0.42
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from8 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
2,827.20 | #1 23,633.06 | 48.90 | #1 2,295.80 | 11.52 | #1 362 | 81.24 | 59.23 | |
948.60 | #2 9,736.08 | #10 68.18 | #6 568.60 | #5 20.11 | #3 120 | #7 3.56 | 47.66 | |
1,670.00 | 8,563.95 | 59.54 | 1,216.80 | 4.59 | 129 | -20.00 | 51.69 | |
1,017.00 | 5,389.43 | 58.64 | 581.30 | 8.63 | 70 | 25.58 | 70.24 | |
642.30 | 2,073.97 | 27.00 | 636.40 | 25.65 | 57 | 10.70 | 36.73 | |
336.90 | 1,754.60 | 53.74 | 222.30 | 14.77 | 23 | 33.33 | 64.60 | |
1,902.25 | 1,632.68 | 35.19 | 86.70 | 25.47 | 32 | 58.82 | 70.27 | |
271.10 | 862.38 | #1 8.33 | 1,436.10 | 35.04 | 6 | -1,081.25 | 55.27 | |
240.65 | 174.30 | 15.19 | 63.00 | #1 248.07 | 7 | #1 133.33 | 42.71 | |
109.00 | 75.20 | 58.67 | 36.90 | 6.34 | 1 | 0.00 | 39.97 |
Forecast
Actual
Growth Rate
Revenue Growth
20.11 %
Net Income Growth
40.38 %
Cash Flow Change
11.35 %
ROE
16.29 %
ROCE
17.56 %
EBITDA Margin (Avg.)
2.58 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 234 | 301 | 482 | 541 | 714 | 853 | 983 |
| Fixed Assets | 119 | 151 | 272 | 268 | 371 | 524 | 742 |
| Current Assets | 103 | 138 | 186 | 239 | 270 | 276 | 211 |
| Capital Work in Progress | 3 | 3 | 10 | 9 | 34 | 28 | 9 |
| Investments | 73 | 69 | 55 | 28 | 54 | 139 | 109 |
| Other Assets | 39 | 78 | 146 | 236 | 255 | 163 | 123 |
| Total Liabilities | 234 | 301 | 482 | 541 | 714 | 853 | 983 |
| Current Liabilities | 40 | 50 | 59 | 44 | 66 | 66 | 73 |
| Non Current Liabilities | 33 | 40 | 150 | 138 | 178 | 241 | 250 |
| Total Equity | 161 | 211 | 274 | 359 | 470 | 547 | 660 |
| Reserve & Surplus | 155 | 204 | 270 | 355 | 458 | 535 | 647 |
| Share Capital | 5 | 5 | 5 | 5 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -44 | -7 | 46 | -49 | 4 | 13 | -2 |
| Investing Activities | -98 | -90 | -31 | -130 | -123 | -110 | -141 |
| Operating Activities | 62 | 91 | 106 | 130 | 158 | 165 | 183 |
| Financing Activities | -8 | -7 | -30 | -49 | -31 | -42 | -45 |
Share Holding
| % Holding | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 60.00 % | 54.78 % | 54.78 % | 54.78 % | 55.04 % | 55.01 % | 55.01 % | 55.01 % | 54.98 % | 54.90 % | 54.87 % | 54.06 % | 53.93 % | 53.91 % | 53.91 % | 53.05 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 20.09 % | 20.08 % | 18.14 % | 17.54 % | 19.36 % |
| DIIs | 0.00 % | 14.09 % | 13.30 % | 12.88 % | 12.76 % | 15.28 % | 14.23 % | 13.90 % | 19.03 % | 17.99 % | 19.55 % | 20.80 % | 21.49 % | 23.46 % | 24.63 % | 23.72 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 5.45 % | 3.71 % | 3.82 % | 4.00 % | 4.97 % | 5.18 % | 5.13 % | 5.03 % | 5.06 % | 4.63 % | 4.38 % | 3.98 % | 3.94 % | 3.43 % | 3.42 % |
| Others | 40.00 % | 25.68 % | 28.21 % | 28.52 % | 28.20 % | 24.74 % | 25.58 % | 25.96 % | 20.96 % | 22.05 % | 20.95 % | 0.67 % | 0.52 % | 0.55 % | 0.49 % | 0.45 % |
| No of Share Holders | 7 | 2,34,724 | 82,139 | 79,021 | 77,229 | 76,985 | 79,059 | 76,532 | 73,850 | 72,795 | 66,204 | 66,724 | 62,415 | 62,258 | 60,952 | 66,891 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.16 | 0.1 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 12 May 2025 |  Quarterly Result Announcement | NA | 12 May 2025 | 1,018.20 | 993.10 |
| 25 Apr 2025 |  Extraordinary General Meeting | NA | 25 Apr 2025 | 1,050.75 | 1,061.80 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 1,160.00 | 1,078.50 |
| 07 Nov 2024 | Quarterly Result Announcement | NA | 07 Nov 2024 | 934.40 | 980.25 |
| 06 Sept 2024 |  Annual General Meeting | NA | 06 Sept 2024 | 819.80 | 947.20 |
| 30 Aug 2024 |  Dividend | ₹ 1.00 /share | 30 Aug 2024 | 666.05 | 892.05 |
| 13 Sept 2023 | Dividend | ₹ 1.00 /share | 13 Sept 2023 | 376.05 | 473.60 |
| 21 Sept 2022 | Dividend | ₹ 1.00 /share | 20 Sept 2022 | 389.20 | 402.80 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2025
May 12, 2025Corporate Action-Board approves DividendMay 12, 2025
May 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th May 2025May 12, 2025
May 12, 2025Financial Results - For The 4Th Quarter And Financial Year Ended March 31 2025May 12, 2025
May 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 06, 2025
May 06, 2025Board Meeting Intimation for Approval Of Audited Financial Results For FY 2024-25 And Other Corporate MattersMay 06, 2025
May 06, 2025Unsecured Creditors Meeting - Scrutinizers Report And Voting ResultsApr 28, 2025
Apr 28, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 28, 2025
Apr 28, 2025Proceedings Of Meeting Of Unsecured CreditorsApr 25, 2025
Apr 25, 2025Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingApr 25, 2025
Apr 25, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Apr 04, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Mar 26, 2025
Mar 26, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2025
Mar 25, 2025Notice Of Meeting Of The Unsecured Creditors Of Vijaya Diagnostic Centre Limited To Be Convened As Per The Directions Provided In The Order Of The HonBle National Company Law TribunalMar 25, 2025
Mar 25, 2025Notice Of Meeting Of The Equity Shareholders Of Vijaya Diagnostic Centre Limited To Be Convened As Per The Directions Provided In The Order Of The HonBle National Company Law TribunalMar 25, 2025
Mar 25, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2025
Feb 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2025
Feb 12, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Feb 12, 2025Unaudited Financial Results For Q3 FY2025Feb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2025
Feb 06, 2025Board Meeting Intimation for Approval Of The Unaudited (Standalone And Consolidated) Financial Results Of The CompanyFeb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-AllotmentFeb 04, 2025
Feb 04, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJan 13, 2025
Jan 13, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jan 13, 2025
Jan 13, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Receipt Of Observation Letters From BSE Limited With No Adverse Observations And National Stock Exchange Of India Limited With No Objection For The Scheme Of AmalgamationDec 07, 2024
Dec 07, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 18, 2024
Nov 18, 2024Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 12, 2024
Nov 12, 2024Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Nov 11, 2024
Nov 11, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2024
Nov 08, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2024
Nov 07, 2024Announcement under Regulation 30 (LODR)-AllotmentNov 07, 2024
Nov 07, 2024Announcement under Regulation 30 (LODR)-Change in ManagementNov 07, 2024
Nov 07, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2024
Nov 07, 2024Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2024
Nov 07, 2024Board Meeting Outcome for Outcome Of The Board Meeting Held On Nov 7, 2024Nov 07, 2024
Nov 07, 2024Unaudited Financial Results For The Quarter And Half Year Ended Sep 30, 2024Nov 07, 2024
Nov 07, 2024Technical Indicators
RSI(14)
Neutral 47.66
ATR(14)
Volatile 42.23
STOCH(9,6)
Neutral 39.35
STOCH RSI(14)
Neutral 68.80
MACD(12,26)
Bearish -0.38
ADX(14)
Weak Trend 8.14
UO(9)
Bearish 45.40
ROC(12)
Downtrend And Accelerating -3.82
WillR(14)
Neutral -58.61
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 Motilal Oswal Active Momentum Fund Direct - Growth | 0 | 0.00% | -3.09% | 0.00% | Apr 2025 | |
 Union Active Momentum Fund Direct-Growth | 0 | 0.00% | -2.01% | 0.00% | Apr 2025 | |
 Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth | 78210 | 0.96% | -0.55% | -1.73% | Apr 2025 | |
 Axis Consumption Fund Direct-Growth | 272123 | 0.66% | -0.46% | -0.40% | Apr 2025 | |
 Edelweiss Multi Cap Fund Direct - Growth | 129649 | 0.49% | -0.37% | -0.56% | Apr 2025 | |
| Motilal Oswal Small Cap Fund Direct - Growth | 980408 | 2.26% | -0.28% | -1.00% | Apr 2025 | |
 Bank of India Multi Cap Fund Direct-Growth | 111445 | 1.40% | -0.27% | -0.53% | Apr 2025 | |
 TRUSTMF Small Cap Fund Direct-Growth | 95229 | 1.12% | -0.26% | -0.61% | Apr 2025 | |
 Kotak Business Cycle Fund Direct - Growth | 704451 | 2.71% | -0.24% | -0.17% | Apr 2025 | |
 WhiteOak Capital Pharma and Healthcare Fund Direct - Growth | 30274 | 0.95% | -0.20% | -0.37% | Apr 2025 | |
 DSP Healthcare Fund Direct - Growth | 935530 | 3.21% | -0.19% | 0.05% | Apr 2025 | |
| Bank of India Large & Mid Cap Equity Fund Direct-Growth | 39679 | 1.05% | -0.19% | -0.44% | Apr 2025 | |
| Kotak Small Cap Fund Direct-Growth | 4756806 | 3.00% | -0.15% | -0.13% | Apr 2025 | |
| Bank of India Small Cap Fund Direct-Growth | 413000 | 2.52% | -0.12% | -0.20% | Apr 2025 | |
 Nippon India Pharma Fund Direct-Growth | 2831564 | 3.43% | -0.10% | 0.02% | Apr 2025 | |
 HDFC Non-Cyclical Consumer Fund Direct - Growth | 135000 | 1.41% | -0.10% | -0.09% | Apr 2025 | |
| WhiteOak Capital Quality Equity Fund Direct-Growth | 26592 | 0.64% | -0.09% | -0.15% | Apr 2025 | |
 Mirae Asset Great Consumer Fund Direct-Growth | 500000 | 1.22% | -0.09% | -0.49% | Apr 2025 | |
 Shriram Multi Sector Rotation Fund Direct-Growth | 52900 | 2.72% | -0.08% | 2.72% | Apr 2025 | |
 Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth | 0 | 0.00% | -0.07% | -0.06% | Apr 2025 | |
| HDFC Pharma And Healthcare Fund Direct - Growth | 426593 | 2.56% | -0.07% | -0.10% | Apr 2025 | |
| Aditya Birla Sun Life Balanced Advantage Fund Direct-Growth | 326114 | 0.43% | -0.06% | -0.10% | Apr 2025 | |
| Edelweiss Small Cap Fund Direct - Growth | 565691 | 1.34% | -0.06% | -0.05% | Apr 2025 | |
| Mirae Asset Multicap Fund Direct - Growth | 327744 | 0.94% | -0.05% | -0.04% | Apr 2025 | |
| Axis Value Fund Direct-Growth | 58022 | 0.68% | -0.04% | -0.23% | Apr 2025 |
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across 20 cities in India, offering laboratory services, radiology and imaging, cardiology, neurology, and gastroenterology services. In 2021, Vijaya Diagnostic Centre Limited went public with an IPO of Rs 1895.04 crore and its shares were listed on the BSE and NSE.
Listing Date
14 Sept, 2021(3 Years,
44 days)
Chairperson NameSura Surendranath Reddy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
